Managing Common Dermatologic Needs In Transgender And Gender-Diverse Adolescents

April 2025 in “ Current Pediatrics Reports ”

Courtney Smith, Anna Pulminskas, Julie Rogers, Anna Fischer, Chelsea Deitelzweig, Chiagoziem Ohamadike, Leslie P. Lawley, Howa Yeung

acne vulgaris gender-affirming hormone therapy testosterone dermatologic care

TLDR Transgender and gender-diverse teens need specialized skin and mental health care.

The document emphasizes the unique dermatologic needs of transgender and gender-diverse adolescents, particularly the prevalence of acne vulgaris among those undergoing gender-affirming hormone therapy like testosterone. It highlights the mental health implications of dermatologic conditions, noting increased risks of depression and anxiety. The document underscores the necessity for tailored dermatologic care and mental health support to improve overall health outcomes and quality of life for these youth.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

16 / 16 results

research An International Multicenter Retrospective Cohort Study of 203 Patients with Pediatric Androgenetic Alopecia

February 2025 in “Journal of the American Academy of Dermatology”

Standardized treatment protocols are needed for children with androgenetic alopecia.

research Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience

January 2025 in “Clinical Cosmetic and Investigational Dermatology”

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

research Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists

January 2025 in “Dermatology and Therapy”

Hormonal therapies effectively treat acne and improve quality of life.

research Insights Into the Role of Grooming Modifications and Preventative Approaches in Pseudofolliculitis Barbae: A Narrative Review of Hair Removal Practices

2 citations , December 2024 in “JAAD reviews.”

Modifying grooming techniques and using treatments like chemical depilatories or laser hair removal can help manage Pseudofolliculitis barbae.

Efficacy of Topical Minoxidil in Enhancing Beard Growth in Transgender Individuals Assigned Female at Birth on Gender Affirming Hormone Therapy

research Efficacy of Topical Minoxidil in Enhancing Beard Growth in Transgender Individuals Assigned Female at Birth on Gender Affirming Hormone Therapy

April 2024 in “Journal of endocrinological investigation”

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

research Dermatologic Needs of Transgender and Gender Diverse Youth: A Retrospective Cohort Study

April 2024 in “Pediatric dermatology”

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Priorities for Efficacy Trials of Gender-Affirming Hormone Therapy With Estrogen: Collaborative Design and Results of a Community Survey

research Priorities for Efficacy Trials of Gender-Affirming Hormone Therapy With Estrogen: Collaborative Design and Results of a Community Survey

February 2024 in “Hormones”

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Clinical Efficacy and Safety of Low-Dose Oral Minoxidil Versus Topical Solution in the Improvement of Androgenetic Alopecia: A Randomized Controlled Trial

research Clinical Efficacy and Safety of Low-Dose Oral Minoxidil Versus Topical Solution in the Improvement of Androgenetic Alopecia: A Randomized Controlled Trial

November 2023 in “Journal of Cosmetic Dermatology”

Oral minoxidil is more convenient but topical minoxidil improves hair density better.

research Effect of Gender-Affirming Hormone Therapy on Hair Growth: A Systematic Review of the Literature

June 2023 in “Clinical and Experimental Dermatology”

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.